Getwell Pharma India Private Limited — Doxorubicin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Doxorubicin · $525.9K export value · DGFT Verified
Getwell Pharma India Private Limited is the #11 Indian exporter of Doxorubicin with $525.9K in export value and 81 verified shipments. Getwell Pharma India Private Limited holds a 0.8% market share in Doxorubicin exports across 11 countries. The company exports 10 pharmaceutical products worth $4.6M across 3 therapeutic categories.
Getwell Pharma India Private Limited — Doxorubicin Export Profile: Buyers & Destinations
Where Does Getwell Pharma India Private Limited Export Doxorubicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GEORGIA | $267.1K | 13 | 30.6% |
| PHILIPPINES | $148.6K | 18 | 17.0% |
| BANGLADESH | $143.4K | 17 | 16.4% |
| KENYA | $101.7K | 25 | 11.6% |
| NEPAL | $85.5K | 23 | 9.8% |
| JAMAICA | $41.0K | 23 | 4.7% |
| MYANMAR | $29.5K | 12 | 3.4% |
| REPUBLIC OF KOREA | $10.5K | 1 | 1.2% |
| DOMINICAN REPUBLIC | $9.9K | 2 | 1.1% |
| MAURITIUS | $8.9K | 15 | 1.0% |
Getwell Pharma India Private Limited exports Doxorubicin to 17 countries. The largest destination is GEORGIA accounting for 30.6% of Getwell Pharma India Private Limited's Doxorubicin shipments, followed by PHILIPPINES (17.0%) and BANGLADESH (16.4%). These destinations reflect Getwell Pharma India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Doxorubicin from Getwell Pharma India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MERMISI LLC | GEORGIA | $267.1K | 13 |
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $148.6K | 18 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $71.0K | 17 |
| JANATA BANK LTD. | BANGLADESH | $55.8K | 5 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $48.4K | 13 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $41.0K | 23 |
| JANATA BANK PLC | BANGLADESH | $34.1K | 4 |
| JANATA BANK LTD | BANGLADESH | $31.9K | 2 |
| VISION CARE INTERNATIONAL PRIVATE LIMITED | NEPAL | $30.1K | 7 |
| PHARMAFORTE COMPANY LIMITED | MYANMAR | $24.6K | 10 |
Getwell Pharma India Private Limited supplies Doxorubicin to 31 buyers globally. The largest buyer is MERMISI LLC (GEORGIA), followed by AMBICA INTERNATIONAL CORPORATION (PHILIPPINES) and M/S NAIROBI ENTERPRISES LTD. (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Doxorubicin Export Value and How Much Does Getwell Pharma India Private Limited Contribute?
India exported $21.8M worth of Doxorubicin through 3,492 shipments from 310 suppliers to 136 countries, serving 899 buyers globally. Getwell Pharma India Private Limited contributes $525.9K to this total, accounting for 0.8% of India's Doxorubicin exports. Getwell Pharma India Private Limited ships Doxorubicin to 17 countries through 31 buyers.
What Is the Average Shipment Value for Getwell Pharma India Private Limited's Doxorubicin Exports?
Getwell Pharma India Private Limited's average Doxorubicin shipment value is $6.5K per consignment, based on 81 shipments totaling $525.9K. The largest destination is GEORGIA (30.6% of Getwell Pharma India Private Limited's Doxorubicin exports).
How Does Getwell Pharma India Private Limited Compare to Other Indian Doxorubicin Exporters?
Getwell Pharma India Private Limited ranks #11 among 310 Indian Doxorubicin exporters with a 0.8% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.5M), FRESENIUS KABI ONCOLOGY LIMITED ($3.1M), DR.REDDY'S LABORATORIES LTD ($2.5M). Getwell Pharma India Private Limited processed 81 shipments to 11 destination countries.
What Doxorubicin Formulations Does Getwell Pharma India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Targe-DOX 20MG/10ML (DOXORUBICIN HCL LIP | $117.5K | 4 |
| TARGE-DOX 20MG/10ML (DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION) BATCH NO. 5GID02, MFG.DT. 01/2025, EXP.DT. 12/2026 | $46.3K | 1 |
| TARGE-DOX 20MG/10ML (DOXORUBICIN HCL LIPOSOME INJ.),BATCH NO. 4GID06, MFG.DT. 04/2024, EXP.DT. 03/2026 | $41.5K | 1 |
| DOXORUBA 50MG/25ML (DOXORUBICIN HCl INJE | $32.7K | 9 |
| I DOX 50MG 25ML DOXORUBICIN HCL USP PEGYLATED LIPOSOMAL DOXORUBICIN INJ50MG BT NO 5GID05 MFG DT 03 2025 EXP DT 02 2027 | $31.9K | 2 |
| IDOX 50MG/25ML (DOXORUBICIN HCL LIPOSOME | $31.5K | 5 |
| I-DOX 20MG/10ML (DOXORUBICIN HCL LIPOSOM | $26.6K | 6 |
| DOXOBICIN 50 MG/25ML (DOXORUBICIN HCL INJECTION USP) BATCH NO. 4GDX16, MFG.DT. 12/2024, EXP.DT. 11/2026 | $21.9K | 1 |
| I-DOX 50MG/25 MLBATCH NO. 3GID11, MFG.DT. 08/2023, EXP.DT. 07/2025(PEGYLATED LIPOSOMAL DOXORUBICIN INJECTION 50MG )NOS | $21.8K | 2 |
| ADRICYCLINE 50MG/25ML(DOXORUBICIN HYDROCHLORIDE INJECTION USP) BATCH NO. 5GDX03,MFG.DT. 03/2025, EXP.DT. 02/2027 | $17.9K | 1 |
Getwell Pharma India Private Limited exports 101 distinct Doxorubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Targe-DOX 20MG/10ML (DOXORUBICIN HCL LIP with 4 shipments worth $117.5K.
How Does Getwell Pharma India Private Limited Compare to Nearest Doxorubicin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $1.1M | 85 | 22 | $12.4K |
| 5 | DR REDDYS LABORATORIES LIMITED | $550.0K | 11 | 2 | $50.0K |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED ★ | $525.9K | 81 | 11 | $6.5K |
| 12 | UNITED BIOTECH PRIVATE LIMITED | $508.7K | 111 | 15 | $4.6K |
| 4 | DR.REDDY'S LABORATORIES LIMITED | $500.0K | 10 | 3 | $50.0K |
Getwell Pharma India Private Limited ranks #11 among 310 Indian Doxorubicin exporters. Average shipment value of $6.5K compared to the market average of $70.4K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Doxorubicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 639 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 577 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 464 | 13.3% |
| DELHI AIR | 399 | 11.4% |
| Bombay Air | 188 | 5.4% |
| AHEMDABAD AIR | 150 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 120 | 3.4% |
| Delhi Air | 85 | 2.4% |
What Other Oncology Products Does Getwell Pharma India Private Limited Export?
Getwell Pharma India Private Limited also exports these oncology products. Each links to the detailed product page.
About Getwell Pharma India Private Limited
Getwell Pharma India Private Limited exports 10 products worth $4.6M. Beyond Doxorubicin, top products include Paclitaxel, Protein, Gemcitabine, Fluorouracil, Cyclophosphamide. View the complete Getwell Pharma India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxorubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Doxorubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharma India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 163 individual customs records matching Getwell Pharma India Private Limited exporting Doxorubicin, covering 101 formulations to 17 countries via 31 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 136+ countries, 899+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Doxorubicin Export Data from Getwell Pharma India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharma India Private Limited's Doxorubicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharma India Private Limited
Full Company Profile →
10 products · $4.6M total trade · 3 categories
Doxorubicin Stats
Company Overview
Top Products by Getwell Pharma India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharma India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxorubicin. For current shipment-level data, contact TransData Nexus.